Page last updated: 2024-10-27

flufenamic acid and Acute Confusional Senile Dementia

flufenamic acid has been researched along with Acute Confusional Senile Dementia in 2 studies

Flufenamic Acid: An anthranilic acid derivative with analgesic, anti-inflammatory, and antipyretic properties. It is used in musculoskeletal and joint disorders and administered by mouth and topically. (From Martindale, The Extra Pharmacopoeia, 30th ed, p16)
flufenamic acid : An aromatic amino acid consisting of anthranilic acid carrying an N-(trifluoromethyl)phenyl substituent. An analgesic and anti-inflammatory, it is used in rheumatic disorders.

Research Excerpts

ExcerptRelevanceReference
" Flufenamic acid and mefenamic acid are efficacious in NLRP3-dependent rodent models of inflammation in air pouch and peritoneum."3.83Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent models. ( Allan, SM; Bagnall, J; Baldwin, AG; Booth, SJ; Brough, D; Daniels, MJ; Eder, C; Fasolino, V; Fischer, N; Freeman, S; Galea, J; Harte, MK; Jackson, J; Koziel, V; Latta, C; Lawrence, CB; Paszek, P; Pillot, T; Rivers-Auty, J; Schilling, T; Spencer, NG; Watremez, W; White, CS; Wong, R; Yu, S, 2016)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Cotrina, EY1
Santos, LM1
Rivas, J1
Blasi, D1
Leite, JP1
Liz, MA1
Busquets, MA1
Planas, A1
Prohens, R1
Gimeno, A1
Jiménez-Barbero, J1
Gales, L1
Llop, J1
Quintana, J1
Cardoso, I1
Arsequell, G1
Daniels, MJ1
Rivers-Auty, J1
Schilling, T1
Spencer, NG1
Watremez, W1
Fasolino, V1
Booth, SJ1
White, CS1
Baldwin, AG1
Freeman, S1
Wong, R1
Latta, C1
Yu, S1
Jackson, J1
Fischer, N1
Koziel, V1
Pillot, T1
Bagnall, J1
Allan, SM1
Paszek, P1
Galea, J1
Harte, MK1
Eder, C1
Lawrence, CB1
Brough, D1

Other Studies

2 other studies available for flufenamic acid and Acute Confusional Senile Dementia

ArticleYear
Targeting transthyretin in Alzheimer's disease: Drug discovery of small-molecule chaperones as disease-modifying drug candidates for Alzheimer's disease.
    European journal of medicinal chemistry, 2021, Dec-15, Volume: 226

    Topics: Alzheimer Disease; Calorimetry; Dose-Response Relationship, Drug; Drug Discovery; Humans; Models, Mo

2021
Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent models.
    Nature communications, 2016, 08-11, Volume: 7

    Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone Marrow Cells; Cell Death;

2016